Sustainability/ESG

Sustainability/ESG Initiatives

Materiality (Key Sustainability Issues)

GNI Group Ltd. (“the company”) and its affiliated companies (collectively, “the Group” or “we”) prioritize addressing unmet medical needs—healthcare needs for diseases with no effective treatments—based on its vision of “We Bring New Hope to Life.” Through its pharmaceutical and drug discovery business activities, we uphold its commitment to social responsibility.

 

Access to Treatment for Rare Diseases　　　　　　　　　　　　　　

By developing and marketing treatments for rare diseases, such as ETUARY® for idiopathic pulmonary fibrosis (IPF), which previously had no available treatments, we contribute to improving the health of more people.

Empowering Diverse Talent　　　　　　　　　　　　　　 　  　

As the foundation of our global business operations, we emphasize promoting diversity and inclusion. We are committed to advancing women into management roles and hiring and nurturing talent with diverse racial and cultural backgrounds. Leaders from Asia, the U.S., and Africa, regardless of race or gender, are actively contributing to the Group’s success.

Technological Innovation in Drug Discovery Using AI 　　　　　　 

In collaboration with alt Inc, we leverage AI in both drug discovery and investment, creating new use cases and driving innovation to deliver new value.

Reducing Environmental Impact 　　　　　　　　　　　　　     

As a company supporting health through the development, production, and sale of pharmaceuticals, the Group actively work toward building a sustainable society. We strive to minimize environmental impact across all business activities while focusing on addressing climate change, efficient and sustainable use of resources, and preserving ecosystems.

Promoting Compliance 　　　　　　　　　　　　　　　　　    　       　

To fulfill our “corporate social responsibility,” the Group adheres to relevant laws, internal regulations, and standards. Through internal training and initiatives, we aim to cultivate an organization where every employee acts with a high sense of ethics.